Article
Generalizable transcriptome-based tumor malignant level evaluation and molecular subtyping towards precision oncology.
Journal of translational medicine - 28 May 2024
Hu Dingxue, Zhang Ziteng, Liu Xiaoyi, Wu Youchun, An Yunyun, Wang Wanqiu, Yang Mengqi, Pan Yuqi, Qiao Kun, Du Changzheng, Zhao Yu, Li Yan, Bao Jianqiang, Qin Tao, Pan Yue, Xia Zhaohua, Zhao Xin, Sun Kun
Abstract excerpt
In cancer treatment, therapeutic strategies that integrate tumor-specific characteristics (i.e., precision oncology) are widely implemented to provide clinical benefits for cancer patients. Here, through in-depth integration of tumor transcriptome and patients' prognoses across cancers, we investigated dysregulated and prognosis-associated genes and catalogued such important genes in a cancer type-dependent...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
